Baleeiro R - Search Results

1

Immune checkpoint inhibitors in cancer therapy.

Webb ES, Liu P, Baleeiro R, Lemoine NR, Yuan M, Wang YH. Webb ES, et al. Among authors: baleeiro r. J Biomed Res. 2018 Sep 29;32(5):317-326. doi: 10.7555/JBR.31.20160168. J Biomed Res. 2018. PMID: 28866656 Free PMC article.

2

MHC class II molecules on pancreatic cancer cells indicate a potential for neo-antigen-based immunotherapy.

Baleeiro RB, Bouwens CJ, Liu P, Di Gioia C, Dunmall LSC, Nagano A, Gangeswaran R, Chelala C, Kocher HM, Lemoine NR, Wang Y. Baleeiro RB, et al. Oncoimmunology. 2022 May 27;11(1):2080329. doi: 10.1080/2162402X.2022.2080329. eCollection 2022. Oncoimmunology. 2022. PMID: 35655709 Free PMC article.

3

Optimized Anchor-Modified Peptides Targeting Mutated RAS Are Promising Candidates for Immunotherapy.

Baleeiro RB, Dunmall LSC, Liu P, Lu S, Lone Y, Lemoine NR, Wang Y. Baleeiro RB, et al. Front Immunol. 2022 May 26;13:902709. doi: 10.3389/fimmu.2022.902709. eCollection 2022. Front Immunol. 2022. PMID: 35720289 Free PMC article.

4

Spatial separation of the processing and MHC class I loading compartments for cross-presentation of the tumor-associated antigen HER2/neu by human dendritic cells.

Baleeiro RB, Rietscher R, Diedrich A, Czaplewska JA, Lehr CM, Scherließ R, Hanefeld A, Gottschaldt M, Walden P. Baleeiro RB, et al. Oncoimmunology. 2015 May 26;4(11):e1047585. doi: 10.1080/2162402X.2015.1047585. eCollection 2015 Nov. Oncoimmunology. 2015. PMID: 26985398 Free PMC article.

5

Direct activation of human dendritic cells by particle-bound but not soluble MHC class II ligand.

Baleeiro RB, Wiesmüller KH, Dähne L, Lademann J, Barbuto JA, Walden P. Baleeiro RB, et al. PLoS One. 2013 May 2;8(5):e63039. doi: 10.1371/journal.pone.0063039. Print 2013. PLoS One. 2013. PMID: 23658796 Free PMC article.

6

Immature human DCs efficiently translocate endocytosed antigens into the cytosol for proteasomal processing.

Baleeiro RB, Walden P. Baleeiro RB, et al. Mol Immunol. 2017 Aug;88:148-154. doi: 10.1016/j.molimm.2017.06.028. Epub 2017 Jun 20. Mol Immunol. 2017. PMID: 28644974

7

Nanoparticle-Based Mucosal Vaccines Targeting Tumor-Associated Antigens to Human Dendritic Cells.

Baleeiro RB, Schweinlin M, Rietscher R, Diedrich A, Czaplewska JA, Metzger M, Lehr CM, Scherlieb R, Hanefeld A, Gottschaldt M, Walden P. Baleeiro RB, et al. J Biomed Nanotechnol. 2016 Jul;12(7):1527-43. doi: 10.1166/jbn.2016.2267. J Biomed Nanotechnol. 2016. PMID: 29337492

8

Combining R-DOTAP and a particulate antigen delivery platform to trigger dendritic cell activation: Formulation development and in-vitro interaction studies.

Riehl M, Harms M, Hanefeld A, Baleeiro RB, Walden P, Mäder K. Riehl M, et al. Among authors: baleeiro rb. Int J Pharm. 2017 Oct 30;532(1):37-46. doi: 10.1016/j.ijpharm.2017.08.119. Epub 2017 Sep 1. Int J Pharm. 2017. PMID: 28866132

9

Diverse HLA-I Peptide Repertoires of the APC Lines MUTZ3-Derived Immature and Mature Dendritic Cells and THP1-Derived Macrophages.

Nyambura LW, Jarmalavicius S, Baleeiro RB, Walden P. Nyambura LW, et al. Among authors: baleeiro rb. J Immunol. 2016 Sep 15;197(6):2102-9. doi: 10.4049/jimmunol.1600762. Epub 2016 Aug 19. J Immunol. 2016. PMID: 27543614

10

Topical vaccination with functionalized particles targeting dendritic cells.

Baleeiro RB, Wiesmüller KH, Reiter Y, Baude B, Dähne L, Patzelt A, Lademann J, Barbuto JA, Walden P. Baleeiro RB, et al. J Invest Dermatol. 2013 Aug;133(8):1933-41. doi: 10.1038/jid.2013.79. Epub 2013 Feb 20. J Invest Dermatol. 2013. PMID: 23426134 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters